February 4, 2013 | Icon plans to buy the clinical trial services division of Cross Country Healthcare for $52 million in cash and another $3.75 million in potential milestone payments. Icon provides development services to drug and medical device makers. Cross Country's clinical trial services division provides contract staffing and permanent placement services as well as drug safety work. SF Gate